- 445–457. doi:10.1016/s0006-3223(00)00909-4. PMID 11018218. S2CID 6629039.
Buoli M,
Serati M,
Altamura AC (December 2017). "Biological
aspects and candidate...
- 7, 2022.
Retrieved September 6, 2021.
Fracas E,
Costantino A,
Vecchi M,
Buoli M (June 2023). "Depressive and
Anxiety Disorders in
Patients with Inflammatory...
- Australia. p. 388. ISBN 978-0-7295-3939-5.
Retrieved 27
November 2011.
Buoli M,
Altamura AC (March 2015). "May non-antipsychotic
drugs improve cognition...
- 796–801. doi:10.4088/JCP.v63n0908. PMID 12363120.
Altamura AC, Dell'Osso B,
Buoli M,
Zanoni S,
Mundo E (August 2008). "Intravenous
augmentative citalopram...
-
Archived from the
original (PDF) on 27 May 2016.
Retrieved 7
November 2023.
Buoli M,
Serati M, Cahn W (2016). "Alternative
pharmacological strategies for...
-
hyperactivity disorder". Neurosciences. 18 (4): 323–329. PMID 24141455.
Buoli M,
Serati M, Cahn W (2016). "Alternative
pharmacological strategies for...
- (2): 121–133. doi:10.1177/1060028018795703. PMID 30117329. S2CID 52019992.
Buoli M,
Serati M, Cahn W (2016). "Alternative
pharmacological strategies for...
-
available under the CC BY 4.0 license.
Fracas E,
Costantino A,
Vecchi M,
Buoli M.
Depressive and
Anxiety Disorders in
Patients with
Inflammatory Bowel...
- Publishers. p. 434. ISBN 978-3-88763-101-7.
Retrieved 1
September 2024.
Buoli M,
Serati M, Cahn W (2016). "Alternative
pharmacological strategies for...
-
Archived from the
original on 28
February 2021.
Retrieved 14
January 2021.
Buoli M,
Mauri MC,
Altamura AC (June 2014). "Pharmacokinetic
evaluation of agomelatine...
